Symbols / TECH Stock $58.58 -1.83% Bio-Techne Corporation

Healthcare • Biotechnology • United States • NMS
TECH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Fundamentals
Scroll to Statements
Market Cap 9.17B Enterprise Value 9.34B Income 81.06M Sales 1.22B Book/sh 12.90 Cash/sh 1.15
Dividend Yield 55.00% Payout 60.38% Employees 3100 IPO — P/E 110.53 Forward P/E 27.10
PEG 0.78 P/S 7.54 P/B 4.54 P/C — EV/EBITDA 28.25 EV/Sales 7.68
Quick Ratio 2.59 Current Ratio 4.54 Debt/Eq 17.45 LT Debt/Eq — EPS (ttm) 0.53 EPS next Y 2.16
EPS Growth 9.10% Revenue Growth -0.40% Earnings 2026-05-06 ROA 6.52% ROE 3.97% ROIC —
Gross Margin 66.61% Oper. Margin 19.67% Profit Margin 6.67% Shs Outstand 156.45M Shs Float 154.57M Short Float 10.28%
Short Ratio 6.41 Short Interest — 52W High 72.16 52W Low 46.05 Beta 1.49 Avg Volume 2.32M
Volume 1.09M Target Price $72.27 Recom Buy Prev Close $59.67 Price $58.58 Change -1.83%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$72.27
Mean price target
2. Current target
$58.58
Latest analyst target
3. DCF / Fair value
$29.99
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$58.58
Low
$54.00
High
$80.00
Mean
$72.27

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-06 main Evercore ISI Group In-Line → In-Line $54
2026-02-06 main Wells Fargo Overweight → Overweight $76
2026-02-05 main Citigroup Buy → Buy $80
2026-02-05 main Stifel Hold → Hold $65
2026-02-05 main TD Cowen Buy → Buy $80
2026-02-05 main UBS Buy → Buy $79
2026-02-05 main Evercore ISI Group In-Line → In-Line $68
2026-01-05 down Evercore ISI Group Outperform → In-Line $62
2025-11-20 main Argus Research Buy → Buy $68
2025-11-06 main UBS Buy → Buy $70
2025-11-06 main Wells Fargo Overweight → Overweight $70
2025-10-14 main TD Cowen Buy → Buy $70
2025-10-07 main Evercore ISI Group Outperform → Outperform $72
2025-09-03 up RBC Capital Sector Perform → Outperform $73
2025-08-21 up Citigroup Neutral → Buy $70
2025-08-07 main RBC Capital Sector Perform → Sector Perform $61
2025-07-11 main Scotiabank Sector Outperform → Sector Outperform $75
2025-07-09 init TD Cowen — → Buy $65
2025-06-05 reit Benchmark Buy → Buy $75
2025-05-30 init Wells Fargo — → Overweight $59
News
RSS: Latest TECH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-14 KELDERMAN KIM Chief Executive Officer — 36,500 $47.60 $1,737,400
2026-04-02 BOHNEN SHANE General Counsel — 2,259 — —
2026-02-17 HERR AMY E. Director — 1,976 $59.10 $116,791
2026-02-03 HERR AMY E. Director — 38 — —
2026-01-30 MCMANUS MATTHEW F Officer — 4,621 — —
2025-11-03 HIPPEL JAMES Chief Financial Officer — 24,704 — —
2025-11-03 GEIST WILLIAM Officer — 9,911 — —
2025-10-30 HIGGINS JOHN L Director — 1,640 $0.00 $0
2025-10-30 KEEGAN JOSEPH D Director — 1,640 $0.00 $0
2025-10-30 BAUMGARTNER ROBERT V Director — 1,640 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
1,219.63
+5.23%
1,159.06
+1.97%
1,136.70
+2.81%
1,105.60
Operating Revenue
1,219.63
+5.23%
1,159.06
+1.97%
1,136.70
+2.81%
1,105.60
Cost Of Revenue
429.36
+10.28%
389.33
+6.12%
366.89
+5.09%
349.10
Reconciled Cost Of Revenue
350.75
+13.39%
309.33
+6.04%
291.73
+3.99%
280.53
Gross Profit
790.27
+2.67%
769.73
-0.01%
769.82
+1.76%
756.50
Operating Expense
547.47
+4.61%
523.32
+9.30%
478.82
+3.94%
460.67
Research And Development
99.50
+2.93%
96.66
+4.51%
92.49
+6.14%
87.14
Selling General And Administration
415.10
+5.54%
393.32
+11.60%
352.44
+3.96%
339.00
General And Administrative Expense
415.10
+5.54%
393.32
+11.60%
352.44
+3.96%
339.00
Salaries And Wages
40.86
+3.57%
39.45
-2.03%
40.27
-10.68%
45.09
Other Gand A
374.24
+5.76%
353.87
+13.36%
312.17
+6.21%
293.92
Total Expenses
976.83
+7.03%
912.66
+7.92%
845.70
+4.44%
809.77
Operating Income
242.80
-1.46%
246.40
-15.33%
291.00
-1.63%
295.83
Total Operating Income As Reported
102.25
-50.53%
206.69
-30.86%
298.94
+0.79%
296.59
EBITDA
216.88
-30.74%
313.14
-31.50%
457.11
+10.48%
413.76
Normalized EBITDA
357.57
+0.74%
354.92
-11.48%
400.97
+0.46%
399.15
Reconciled Depreciation
109.90
-1.62%
111.71
+4.17%
107.24
+6.10%
101.07
EBIT
106.97
-46.89%
201.43
-42.43%
349.87
+11.89%
312.69
Total Unusual Items
-140.69
-236.68%
-41.79
-174.44%
56.14
+284.20%
14.61
Total Unusual Items Excluding Goodwill
-140.69
-236.68%
-41.79
-174.44%
56.14
+284.20%
14.61
Special Income Charges
-142.14
-243.79%
-41.34
-773.81%
6.14
+582.01%
-1.27
Other Special Charges
41.83
+1093.01%
3.51
—
—
Restructuring And Mergern Acquisition
19.81
+24.77%
15.88
+358.74%
-6.14
+64.82%
-17.44
Write Off
80.50
+266.54%
21.96
0.00
-100.00%
18.71
Net Income
73.40
-56.34%
168.10
-41.07%
285.26
+4.86%
272.05
Pretax Income
98.46
-46.97%
185.69
-45.17%
338.66
+12.37%
301.39
Net Non Operating Interest Income Expense
-4.62
+62.76%
-12.41
-59.04%
-7.80
+25.77%
-10.52
Interest Expense Non Operating
8.51
-45.93%
15.74
+40.31%
11.21
-0.83%
11.31
Net Interest Income
-4.62
+62.76%
-12.41
-59.04%
-7.80
+25.77%
-10.52
Interest Expense
8.51
-45.93%
15.74
+40.31%
11.21
-0.83%
11.31
Interest Income Non Operating
3.89
+16.94%
3.32
-2.55%
3.41
+329.47%
0.79
Interest Income
3.89
+16.94%
3.32
-2.55%
3.41
+329.47%
0.79
Other Income Expense
-139.72
-189.28%
-48.30
-187.08%
55.47
+245.09%
16.07
Other Non Operating Income Expenses
0.04
-89.09%
0.33
-29.64%
0.47
-67.90%
1.46
Gain On Sale Of Security
1.45
+426.64%
-0.44
-100.89%
50.00
+214.79%
15.88
Tax Provision
25.06
+42.53%
17.58
-66.96%
53.22
+38.99%
38.29
Tax Rate For Calcs
0.00
+168.42%
0.00
-39.49%
0.00
+23.62%
0.00
Tax Effect Of Unusual Items
-35.88
-803.72%
-3.97
-145.04%
8.81
+374.96%
1.86
Net Income Including Noncontrolling Interests
73.40
-56.34%
168.10
-41.11%
285.44
+8.49%
263.10
Net Income From Continuing Operation Net Minority Interest
73.40
-56.34%
168.10
-41.07%
285.26
+4.86%
272.05
Net Income From Continuing And Discontinued Operation
73.40
-56.34%
168.10
-41.07%
285.26
+4.86%
272.05
Net Income Continuous Operations
73.40
-56.34%
168.10
-41.11%
285.44
+8.49%
263.10
Minority Interests
0.00
0.00
+100.00%
-0.18
-102.00%
8.95
Normalized Income
178.22
-13.46%
205.92
-13.45%
237.94
-8.24%
259.29
Net Income Common Stockholders
73.36
-56.35%
168.07
-41.07%
285.19
+4.88%
271.93
Otherunder Preferred Stock Dividend
0.04
+12.12%
0.03
-52.86%
0.07
-42.15%
0.12
Diluted EPS
0.46
-56.19%
1.05
-40.34%
1.76
+6.18%
1.66
Basic EPS
0.47
-56.07%
1.07
-40.88%
1.81
+4.47%
1.73
Basic Average Shares
157.52
-0.12%
157.71
+0.34%
157.18
+0.19%
156.88
Diluted Average Shares
159.72
-0.66%
160.77
-0.67%
161.85
-1.38%
164.12
Diluted NI Availto Com Stockholders
73.36
-56.35%
168.07
-41.07%
285.19
+4.88%
271.93
Amortization
31.29
-1.34%
31.71
-1.14%
32.08
-1.28%
32.49
Amortization Of Intangibles Income Statement
31.29
-1.34%
31.71
-1.14%
32.08
-1.28%
32.49
Depreciation Amortization Depletion Income Statement
31.29
-1.34%
31.71
-1.14%
32.08
-1.28%
32.49
Depreciation And Amortization In Income Statement
31.29
-1.34%
31.71
-1.14%
32.08
-1.28%
32.49
Earnings From Equity Interest
0.94
+113.71%
-6.84
-498.51%
-1.14
0.00
Other Taxes
1.59
-2.45%
1.63
-9.94%
1.81
-11.06%
2.04
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
2,557.87
-5.40%
2,703.87
+2.47%
2,638.69
+14.99%
2,294.80
Current Assets
608.30
-1.48%
617.42
-0.65%
621.48
+2.63%
605.56
Cash Cash Equivalents And Short Term Investments
162.19
+6.10%
152.86
-25.18%
204.31
-17.29%
247.03
Cash And Cash Equivalents
162.19
+6.85%
151.79
-15.94%
180.57
+4.64%
172.57
Other Short Term Investments
0.00
-100.00%
1.07
-95.48%
23.74
-68.12%
74.46
Receivables
206.88
-14.30%
241.39
+10.49%
218.47
+12.30%
194.55
Accounts Receivable
206.88
-14.30%
241.39
+10.49%
218.47
+12.30%
194.55
Gross Accounts Receivable
211.09
-14.11%
245.78
+10.11%
223.21
+13.24%
197.12
Allowance For Doubtful Accounts Receivable
-4.21
+3.90%
-4.39
+7.43%
-4.74
-84.50%
-2.57
Inventory
189.45
+5.41%
179.73
+4.72%
171.64
+21.62%
141.12
Raw Materials
89.08
+12.22%
79.38
-6.12%
84.55
+6.63%
79.29
Finished Goods
100.37
+0.01%
100.35
+15.23%
87.09
+40.84%
61.83
Assets Held For Sale Current
12.33
+26.18%
9.77
0.00
—
Other Current Assets
37.46
+11.30%
33.66
+24.36%
27.07
+18.42%
22.86
Total Non Current Assets
1,949.57
-6.56%
2,086.45
+3.43%
2,017.21
+19.41%
1,689.25
Net PPE
319.12
-6.81%
342.44
+5.52%
324.53
+12.37%
288.80
Gross PPE
605.25
+1.04%
599.00
+7.30%
558.24
+11.60%
500.22
Accumulated Depreciation
-286.13
-11.53%
-256.56
-9.77%
-233.71
-10.54%
-211.42
Properties
0.00
0.00
0.00
0.00
Land And Improvements
8.15
+0.01%
8.15
-10.44%
9.10
+6.16%
8.57
Buildings And Improvements
254.35
+4.30%
243.86
-0.59%
245.30
+6.86%
229.55
Machinery Furniture Equipment
245.92
+13.88%
215.95
+13.65%
190.02
+8.70%
174.81
Construction In Progress
23.42
-41.08%
39.75
+156.59%
15.49
-28.71%
21.73
Other Properties
73.40
-19.59%
91.28
-7.16%
98.33
+49.99%
65.56
Goodwill And Other Intangible Assets
1,346.53
-9.00%
1,479.74
+5.14%
1,407.38
+3.97%
1,353.62
Goodwill
980.93
+0.85%
972.66
+11.45%
872.74
+6.16%
822.10
Other Intangible Assets
365.60
-27.90%
507.08
-5.16%
534.64
+0.59%
531.52
Investments And Advances
250.98
+3.57%
242.34
-5.28%
255.86
+923.43%
25.00
Long Term Equity Investment
235.98
-2.62%
242.34
-5.28%
255.86
+923.43%
25.00
Other Investments
15.00
0.00
—
—
Non Current Deferred Assets
10.31
0.00
—
—
Non Current Deferred Taxes Assets
10.31
0.00
—
—
Other Non Current Assets
19.78
+63.29%
12.12
-3.76%
12.59
+16.53%
10.80
Total Liabilities Net Minority Interest
639.06
+0.64%
635.02
-5.53%
672.18
+13.20%
593.79
Current Liabilities
175.85
+10.33%
159.38
+24.02%
128.51
-26.99%
176.02
Payables And Accrued Expenses
127.53
+9.59%
116.38
+25.37%
92.83
-26.87%
126.94
Payables
36.08
-13.42%
41.67
+1.15%
41.20
-12.53%
47.10
Accounts Payable
25.31
-33.34%
37.97
+47.86%
25.68
-24.17%
33.87
Other Payable
—
—
3.50
—
Current Accrued Expenses
91.45
+22.42%
74.70
+44.70%
51.63
-35.34%
79.84
Total Tax Payable
10.77
+190.61%
3.71
-69.17%
12.02
-9.18%
13.24
Income Tax Payable
10.77
+190.61%
3.71
-69.17%
12.02
-9.18%
13.24
Current Debt And Capital Lease Obligation
14.10
+9.12%
12.92
+15.37%
11.20
-54.16%
24.43
Current Debt
—
—
—
12.50
Other Current Borrowings
—
—
—
12.50
Current Capital Lease Obligation
14.10
+9.12%
12.92
+15.37%
11.20
-6.11%
11.93
Current Deferred Liabilities
32.57
+16.62%
27.93
+21.07%
23.07
-1.44%
23.41
Current Deferred Revenue
32.57
+16.62%
27.93
+21.07%
23.07
-1.44%
23.41
Other Current Liabilities
1.65
-23.52%
2.15
+52.23%
1.41
+13.68%
1.24
Total Non Current Liabilities Net Minority Interest
463.21
-2.61%
475.64
-12.51%
543.67
+30.13%
417.78
Long Term Debt And Capital Lease Obligation
429.96
+5.74%
406.62
-8.37%
443.77
+47.17%
301.54
Long Term Debt
346.00
+8.46%
319.00
-8.86%
350.00
+43.79%
243.41
Long Term Capital Lease Obligation
83.96
-4.17%
87.62
-6.56%
93.77
+61.30%
58.13
Tradeand Other Payables Non Current
—
—
0.00
-100.00%
5.00
Non Current Deferred Liabilities
6.17
-88.96%
55.86
-37.22%
88.98
-10.11%
98.99
Non Current Deferred Taxes Liabilities
6.17
-88.96%
55.86
-37.22%
88.98
-10.11%
98.99
Other Non Current Liabilities
27.08
+105.84%
13.16
+20.50%
10.92
-10.79%
12.24
Stockholders Equity
1,918.81
-7.25%
2,068.85
+5.20%
1,966.52
+15.56%
1,701.77
Common Stock Equity
1,918.81
-7.25%
2,068.85
+5.20%
1,966.52
+15.56%
1,701.77
Capital Stock
1.55
-2.02%
1.58
+0.38%
1.58
+0.64%
1.57
Common Stock
1.55
-2.02%
1.58
+0.38%
1.58
+0.64%
1.57
Share Issued
154.97
-2.05%
158.22
+0.36%
157.64
+0.64%
156.64
Ordinary Shares Number
154.97
-2.05%
158.22
+0.36%
157.64
+0.64%
156.64
Additional Paid In Capital
911.09
+11.06%
820.34
+13.69%
721.54
+10.59%
652.47
Retained Earnings
1,066.05
-19.56%
1,325.25
+1.21%
1,309.46
+16.61%
1,122.94
Gains Losses Not Affecting Retained Earnings
-59.88
+23.54%
-78.32
-18.55%
-66.06
+12.15%
-75.20
Minority Interest
0.00
0.00
0.00
+100.00%
-0.76
Other Equity Adjustments
-59.88
+23.54%
-78.32
-18.55%
-66.06
+12.15%
-75.20
Total Equity Gross Minority Interest
1,918.81
-7.25%
2,068.85
+5.20%
1,966.52
+15.61%
1,701.01
Total Capitalization
2,264.81
-5.15%
2,387.85
+3.08%
2,316.52
+19.09%
1,945.18
Working Capital
432.45
-5.59%
458.04
-7.09%
492.97
+14.77%
429.54
Invested Capital
2,264.81
-5.15%
2,387.85
+3.08%
2,316.52
+18.33%
1,957.68
Total Debt
444.06
+5.84%
419.54
-7.79%
454.96
+39.57%
325.97
Net Debt
183.81
+9.93%
167.21
-1.31%
169.43
+103.29%
83.34
Capital Lease Obligations
98.06
-2.47%
100.54
-4.22%
104.97
+49.82%
70.06
Net Tangible Assets
572.27
-2.86%
589.11
+5.36%
559.13
+60.60%
348.15
Tangible Book Value
572.27
-2.86%
589.11
+5.36%
559.13
+60.60%
348.15
Financial Assets
2.84
-71.03%
9.81
-41.79%
16.86
+52.88%
11.03
Investments In Other Ventures Under Equity Method
235.98
-2.62%
242.34
-5.28%
255.86
+923.43%
25.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
287.56
-3.82%
298.98
+17.53%
254.39
-21.79%
325.27
Cash Flow From Continuing Operating Activities
287.56
-3.82%
298.98
+17.53%
254.39
-21.79%
325.27
Net Income From Continuing Operations
73.40
-56.34%
168.10
-41.11%
285.44
+8.49%
263.10
Depreciation Amortization Depletion
109.90
-1.62%
111.71
+4.17%
107.24
+6.10%
101.07
Depreciation And Amortization
109.90
-1.62%
111.71
+4.17%
107.24
+6.10%
101.07
Other Non Cash Items
2.11
+377.03%
-0.76
+92.11%
-9.66
+57.34%
-22.64
Stock Based Compensation
40.83
+7.34%
38.04
-3.03%
39.23
-7.00%
42.18
Asset Impairment Charge
101.81
+313.93%
24.60
0.00
-100.00%
19.26
Deferred Tax
-51.11
-29.56%
-39.45
-33.42%
-29.57
-533.79%
6.82
Deferred Income Tax
-51.11
-29.56%
-39.45
-33.42%
-29.57
-533.79%
6.82
Operating Gains Losses
-0.94
-113.71%
6.84
+114.34%
-47.72
—
Gain Loss On Investment Securities
—
—
-37.18
—
Unrealized Gain Loss On Investment Securities
—
-0.28
+40.04%
-0.47
+96.85%
-15.00
Change In Working Capital
11.54
+214.18%
-10.11
+88.84%
-90.58
-30.29%
-69.52
Change In Receivables
42.60
+236.84%
-31.13
-33.28%
-23.36
+59.44%
-57.60
Changes In Account Receivables
34.13
+266.23%
-20.53
+1.60%
-20.87
—
Change In Inventory
-18.14
-27.64%
-14.21
+52.88%
-30.17
+5.75%
-32.01
Change In Prepaid Assets
-14.37
-356.83%
-3.15
+31.38%
-4.58
-48.77%
-3.08
Change In Payables And Accrued Expense
1.45
-96.21%
38.39
+218.24%
-32.47
-240.13%
23.17
Change In Accrued Expense
15.41
+22.11%
12.62
+151.38%
-24.56
-416.47%
7.76
Change In Payable
-13.95
-154.15%
25.77
+425.86%
-7.91
-151.32%
15.41
Change In Account Payable
-13.95
-154.15%
25.77
+425.86%
-7.91
-162.07%
12.74
Investing Cash Flow
-35.18
+82.67%
-203.03
+23.57%
-265.65
-174.29%
-96.85
Cash Flow From Continuing Investing Activities
-35.18
+82.67%
-203.03
+23.57%
-265.65
-174.29%
-96.85
Net PPE Purchase And Sale
-31.01
+50.69%
-62.88
-64.41%
-38.24
+14.84%
-44.91
Purchase Of PPE
-31.01
+50.69%
-62.88
-64.41%
-38.24
+14.84%
-44.91
Capital Expenditure
-31.01
+50.69%
-62.88
-64.41%
-38.24
+14.84%
-44.91
Net Investment Purchase And Sale
1.08
-95.19%
22.56
-74.35%
87.95
+269.33%
-51.94
Purchase Of Investment
0.00
+100.00%
-5.53
+73.04%
-20.50
+73.72%
-78.00
Sale Of Investment
1.08
-96.14%
28.08
-74.11%
108.45
+316.25%
26.05
Net Business Purchase And Sale
-15.00
+91.16%
-169.71
-103.58%
-83.36
0.00
Purchase Of Business
-15.00
+91.16%
-169.71
-67.72%
-101.18
0.00
Gain Loss On Sale Of Business
0.00
0.00
+100.00%
-11.68
0.00
Net Other Investing Changes
2.45
—
—
—
Financing Cash Flow
-253.91
-107.44%
-122.40
-641.20%
22.62
+109.31%
-242.85
Cash Flow From Continuing Financing Activities
-253.91
-107.44%
-122.40
-641.20%
22.62
+109.31%
-242.85
Net Issuance Payments Of Debt
27.00
+187.10%
-31.00
-132.98%
94.00
+209.94%
-85.50
Issuance Of Debt
104.00
-53.78%
225.00
-63.69%
619.66
+588.51%
90.00
Repayment Of Debt
-77.00
+69.92%
-256.00
+51.30%
-525.66
-199.52%
-175.50
Long Term Debt Issuance
104.00
-53.78%
225.00
-63.69%
619.66
+588.51%
90.00
Long Term Debt Payments
-77.00
+69.92%
-256.00
+51.30%
-525.66
-199.52%
-175.50
Net Long Term Debt Issuance
27.00
+187.10%
-31.00
-132.98%
94.00
+209.94%
-85.50
Short Term Debt Issuance
—
—
619.66
+588.51%
90.00
Short Term Debt Payments
—
—
—
-175.50
Net Short Term Debt Issuance
—
—
619.66
+824.75%
-85.50
Net Common Stock Issuance
-275.73
-244.48%
-80.04
-309.17%
-19.56
+87.85%
-160.95
Common Stock Payments
-275.73
-244.48%
-80.04
-309.17%
-19.56
+87.85%
-160.95
Common Stock Dividend Paid
-50.39
+0.06%
-50.42
-0.27%
-50.28
-0.20%
-50.19
Cash Dividends Paid
-50.39
+0.06%
-50.42
-0.27%
-50.28
-0.20%
-50.19
Repurchase Of Capital Stock
-275.73
-244.48%
-80.04
-309.17%
-19.56
+87.85%
-160.95
Proceeds From Stock Option Exercised
51.74
-15.09%
60.94
+104.39%
29.81
-61.36%
77.16
Net Other Financing Charges
-6.52
+70.18%
-21.87
+30.23%
-31.35
-34.13%
-23.37
Changes In Cash
-1.53
+94.21%
-26.45
-332.81%
11.36
+178.71%
-14.43
Effect Of Exchange Rate Changes
11.93
+611.23%
-2.33
+30.48%
-3.36
+72.25%
-12.09
Beginning Cash Position
151.79
-15.94%
180.57
+4.64%
172.57
-13.32%
199.09
End Cash Position
162.19
+6.85%
151.79
-15.94%
180.57
+4.64%
172.57
Free Cash Flow
256.55
+8.66%
236.10
+9.23%
216.15
-22.90%
280.36
Interest Paid Supplemental Data
18.95
+30.71%
14.50
+73.30%
8.37
-24.11%
11.03
Income Tax Paid Supplemental Data
74.36
+13.95%
65.25
-26.21%
88.43
+191.45%
30.34
Change In Income Tax Payable
—
-10.60
-325.32%
-2.49
-193.44%
2.67
Change In Tax Payable
—
-10.60
-325.32%
-2.49
-193.44%
2.67
Dividends Received CFI
7.29
+4.20%
7.00
+103.02%
-232.00
0.00
Earnings Losses From Equity Investments
-0.94
-113.71%
6.84
+498.51%
1.14
0.00
Sale Of Business
0.00
0.00
-100.00%
17.82
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category